Literature DB >> 8540814

Plasmapheresis as preparatory method for thymectomy in myasthenia gravis.

J C Seggia1, P Abreu, M Takatani.   

Abstract

To study the effects of plasmapheresis in preparation for thymectomy, two groups of 40 patients were selected from a sample of 286 patients with myasthenia gravis examined by the first author Group 1 included patients (15 male and 25 female; age range 8-64 yrs) who underwent thymectomy without previous plasmapheresis, whereas patients in group 2 (17 male and 23 female; age range 11-61 yrs) were thymectomized after plasmapheresis. We required patients to have a minimum follow-up period of 12 months to be included in the study. A clinical evaluation protocol composed of 76 items was developed for the study. We found significant improvement in respiratory function and muscular strength in patients thymetomized after plasmapheresis. Furthermore, the combined treatment reduced cost and length of hospital stay. Therefore, we conclude that plasmapheresis should be considered as a coadjuvant to thymectomy in the treatment of myasthenia gravis.

Entities:  

Mesh:

Year:  1995        PMID: 8540814     DOI: 10.1590/s0004-282x1995000300007

Source DB:  PubMed          Journal:  Arq Neuropsiquiatr        ISSN: 0004-282X            Impact factor:   1.420


  5 in total

1.  Ectopic cervical thymoma with myasthenia gravis: a rare association.

Authors:  Rachid Marouf; Ihsan Alloubi; Brahim Housni
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2020-01-03

2.  Thymectomy for Myasthenia Gravis.

Authors:  Gary S. Gronseth; Richard J. Barohn
Journal:  Curr Treat Options Neurol       Date:  2002-05       Impact factor: 3.598

Review 3.  Thymectomy in Myasthenia Gravis.

Authors:  Yener Aydin; Ali Bilal Ulas; Vahit Mutlu; Abdurrahim Colak; Atilla Eroglu
Journal:  Eurasian J Med       Date:  2017-02

4.  Therapeutic plasma exchange in the treatment of myasthenia gravis.

Authors:  Rajesh Kumar; S Paul Birinder; Sonia Gupta; Gagandeep Singh; Amarjit Kaur
Journal:  Indian J Crit Care Med       Date:  2015-01

5.  Intravenous immunoglobulin to prevent myasthenic crisis after thymectomy and other procedures can be omitted in patients with well-controlled myasthenia gravis.

Authors:  Josep Gamez; María Salvadó; Francesc Carmona; Miriam de Nadal; Laura Romero; Daniel Ruiz; Alberto Jáuregui; Olga Martínez; Javier Pérez; Pilar Suñé; María Deu
Journal:  Ther Adv Neurol Disord       Date:  2019-07-17       Impact factor: 6.570

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.